2.122.612 (B) (7202187). - 24 JANVIER 1972. BENZENE-SULFONYL-UREES ET MEDICAMENT CONTENANT CES SUBSTANCESsdPatent

Erbicidi solfonilureici = Herbicides de la famille des sulfonylurées = Sulfonylureic herbicidesBASSI, A.Informatore fitopatologico. 1987, Vol 37, Num 10, pp 19-30, issn 0020-0735Article

Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranesDELEERS, M; BRASSEUR, R.Pharmacological research communications. 1986, Vol 18, Num 2, pp 129-136, issn 0031-6989Article

Sulphonylureas in pregnancySTEEL, J. M; JOHNSTONE, F. D; TOLMIE, J et al.Lancet (British edition). 1991, Vol 338, Num 8776, issn 0140-6736, p. 1222Article

Variation in TCF7L2 influences therapeutic response to sulfonylureas : A GoDARTs studyPEARSON, Ewan R; DONNELLY, Louise A; KIMBER, Charlotte et al.Diabetes (New York, NY). 2007, Vol 56, Num 8, pp 2178-2182, issn 0012-1797, 5 p.Article

Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM)RINAUDO, M. T; CURTO, M; RABBONE, I et al.Journal of diabetes and its complications. 1994, Vol 8, Num 4, pp 221-225, issn 1056-8727Conference Paper

Adsorption of sulfonylureas onto activated charcoal in vitroKANNISTO, H; NEUVONEN, P. J.Journal of pharmaceutical sciences. 1984, Vol 73, Num 2, pp 253-256, issn 0022-3549Article

Extrapancreatic effects of a sulphonylureaKOLLIND, M; ADAMSON, U; LINS, P. E et al.Acta medica Scandinavica. 1984, Vol 215, Num 5, pp 443-445, issn 0001-6101Article

ETUDE CLINIQUE D'UNE NOUVELLE SULFONYLUREE ANTIDIABETIQUE, LE GLIBORNURIDEVERNET A; FABRE J; ZAHND G et al.1972; PRAXIS; SCHWEIZ; DA. 1972; VOL. 61; NO 52; PP. 1599-1607; ABS. ANGL.; BIBL. 13 REF.Serial Issue

TRAITEMENT DU DIABETE INSIPIDE PAR LE CHLORPROPAMIDE CHEZ DES SUJETS ATTEINTS DE XANTHOMATOSEARAPOVA SD.1972; PROBL. ENDOKRINOL.; S.S.S.R.; DA. 1972; VOL. 18; NO 3; PP. 58-59; BIBL. 3REF.Article

2.128.168 (A) (7108106). - 9 MARS 1971. PYRAZINYL-UREES ET MEDICAMENT CONTENANT CES SUBSTANCESsdPatent

Sulfonylurées et effets cardiovasculaires : de l'expérimentation à la clinique. Données disponibles chez l'homme et implications cliniques = Sulfonylureas and cardiovascular effects : From the laboratory to the bedside, clinical data and implications in manRIVELINE, Jean-Pierre; VARROUD-VIAL, Michel; CHARPENTIER, Guillaume et al.STV. Sang thrombose vaisseaux. 2006, Vol 18, Num 7, pp 367-377, issn 0999-7385, 11 p.Article

UNE NOUVELLE MOLECULE SULFONYLUREE. DANS LE TRAITEMENT DES DIABETES NON INSULINO-DEPENDANTS.PLAUCHU M; PHILIPPE LP; OLIVIER J et al.1975; LYON MED.; FR.; DA. 1975; VOL. 233; NO 11; PP. 1201-1203; BIBL. 4 REF.Article

CIRCADIAN VARIATIONS OF CARBOHYDRATE TOLERANCE IN MATURITY ONSET DIABETICS TREATED WITH SULFONYLUREAS = VARIATIONS CIRCADIENNES DE LA TOLERANCE AUX GLUCIDES DANS LE DIABETE DEBUTANT CHEZ L'ADULTE TRAITE AVEC LES SULFONYLUREESGOSCHKE H; DENES A; GIRARD J et al.1974; HORMONE METABOL. RES.; GERM.; DA. 1974; VOL. 6; NO 5; PP. 386-391; BIBL. 18REF.Article

EFFECT OF PYRIMIDINES AND PURINES ASSOCIATED WITH TOLBUTAMIDE ON REGENERATION OF THE ENDOCRINE PANCREAS OF ALLOXANIZED RATS = EFFET SUR LA REGENERATION DU PANCREAS ENDOCRINE DES PYRIMIDINES ET DES PURINES ASSOCIES AU TOLBUTAMIDE, CHEZ LES RATS RENDUS DIABETIQUES PAR L'ALLOXANECILIEVICI O; STOENESCU P.1974; REV. ROUMAINE ENDOCRINOL.; ROUMAN.; DA. 1974; VOL. 11; NO 3; PP. 197-200; BIBL. 23REF.Article

INFLUENCE DE FONCTIONS RENALES DEFICIENTES SUR LE COMPORTEMENT DE LA GLIPIZIDE (SULFONYLUREE HYPOGLYCEMIANTE) ET DE SES METABOLITESFABRE J; BALANT L; ZAHND G et al.1973; J. UROL NEPHROL.; FR.; DA. 1973; VOL. 79; NO 4-5; PP. 380-381; BIBL. 4 REF.Serial Issue

Fun with mutants: applying genetic methods to problems of weed physiologyCHRISTIANSON, M.L.Weed science. 1991, Vol 39, Num 3, pp 489-496, issn 0043-1745Article

Effect of hypoglycemic sulfonylureas on Ca²⁺ fluxes across lipid bilayersGYLFE, E; HELLMAN, B; ARVIDSON, G et al.Biochemical medicine. 1984, Vol 31, Num 2, pp 246-253, issn 0006-2944Article

Theoretical study on conformation-related activity of hypoglycemic sulfonylureasBRASSEUR, R; DELEERS, M.Pharmacological research communications. 1983, Vol 15, Num 10, pp 901-907, issn 0031-6989Article

Metabolism of sulfometuron-methyl in wheat and its possible role in wheat intoleranceANDERSON, J. J; SWAIN, R. S.Journal of agricultural and food chemistry (Print). 1992, Vol 40, Num 11, pp 2279-2283, issn 0021-8561Article

Recurrent hypoglycemia secondary to drug-dispensing errorSHUMAK, S. L; CORENBLUM, B; STEINER, G et al.Archives of internal medicine (1960). 1991, Vol 151, Num 9, pp 1877-1878, issn 0003-9926Article

Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide)GRAM, J; KOLD, A; JESPERSEN, J et al.Journal of internal medicine. 1989, Vol 225, Num 4, pp 241-247, issn 0954-6820, 7 p.Article

Proceedings/Current research in clinical applications of the second-generation sulfonylurea glyburide, symposium, San Diego CA, April 27-28, 1985OLEFSKY, J. M.The American journal of medicine. 1985, Vol 79, Num 3, issn 0002-9343, 112 p.Conference Proceedings

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapySAGEN, Jørn V; RAEDER, Helge; GLOYN, Anna L et al.Diabetes (New York, NY). 2004, Vol 53, Num 10, pp 2713-2718, issn 0012-1797, 6 p.Article

Potentiation by previous nutrients of glibenclamide-induced insulin release in man. An effect which is counteracted by meal-induced retardation of drug absorptionGRILL, V; EFENDIC, S; REGITZ, G et al.Scandinavian journal of clinical & laboratory investigation. 1986, Vol 46, Num 6, pp 527-532, issn 0036-5513Article